Jane Street Group, LLC Moderna, Inc. Put Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $69.2 Million - $136 Million	1,087,400 New	1,087,400 $72.7 Million
Q1 2022 May 17, 2022	SELL	$126.46 - $235.05 $166 Million - $308 Million	-1,311,500 Reduced 41.23%	1,869,800 $322 Million
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $213 Million - $348 Million	944,200 Added 42.21%	3,181,300 $808 Million
Q3 2021 Nov 16, 2021	BUY	$221.9 - $484.47 $217 Million - $474 Million	978,100 Added 77.69%	2,237,100 $861 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $14.6 Million - $26.4 Million	112,300 Added 9.79%	1,259,000 $296 Million
Q1 2021 May 18, 2021	SELL	$109.18 - $185.98 $9.45 Million - $16.1 Million	-86,600 Reduced 7.02%	1,146,700 $150 Million
Q4 2020 Feb 17, 2021	BUY	$65.74 - $169.86 $6.56 Million - $17 Million	99,800 Added 8.8%	1,233,300 $129 Million
Q3 2020 Nov 17, 2020	BUY	$54.34 - $94.85 $19.5 Million - $34.1 Million	359,000 Added 46.35%	1,133,500 $80.2 Million
Q2 2020 Aug 17, 2020	BUY	$29.67 - $80.0 $16.3 Million - $43.9 Million	549,200 Added 243.76%	774,500 $49.7 Million
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $4.01 Million - $7.11 Million	225,300 New	225,300 $6.75 Million

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.